CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This study aims to investigate the efficacy and safety of tirzepatide in participants with type 2 diabetes (T2D) compared to other existing ...
Phase 4
Milan, Milano, Italy and 89 other locations
also to as NMX8 system), in comparison with other commercially available AID systems (Automated insulin delivery) in adult patients with Type 1 diabetes...
Milan, Italy and 20 other locations
To compare in diabetic patients eligible for percutaneous coronary intervention (PCI) with minimal exclusion criteria, the efficacy and safe...
Milano, Italy and 89 other locations
in pediatric participants aged 10 to less than 18 years with type 2 diabetes. The study will also check how safe these medicines are and how...
Phase 3
Milan, Italy and 70 other locations
The purpose of the study is to evaluate the safety, tolerability, and efficacy of VX-264 in participants with type 1 diabetes (T1D)....
Phase 1, Phase 2
Milan, Italy and 15 other locations
The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.
Phase 3
Milan, Italy and 187 other locations
parallel-arm study to evaluate the efficacy, safety and tolerability of SAB 142 in patients with Stage 3 New Onset of Type 1 Diabetes (NOT1D...
Phase 2
Milan, Italy and 70 other locations
This study will evaluate the safety, tolerability and efficacy of VX-880 infusion in participants with Type 1 diabetes (T1D) and impaired aw...
Phase 3
Milan, Italy and 28 other locations
The purpose of this study is to find out if baricitinib can delay the onset of clinical type 1 diabetes (T1D) in people who are at high risk...
Phase 3
Milan, Italy and 106 other locations
The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM an...
Phase 3
Milan, Italy and 157 other locations
Clinical trials
Research sites
Resources
Legal